Skip Navigation



Rheumatology Advance Access published online on September 27, 2005
Rheumatology, doi:10.1093/rheumatology/kei111
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow CME/CE:
Take the course for this article:
 Rheumatology Fourth Quarter 2005 Quiz
Right arrow All Versions of this Article:
45/1/20    most recent
kei111v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zendman, A. J. W.
Right arrow Articles by Pruijn, G. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zendman, A. J. W.
Right arrow Articles by Pruijn, G. J. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received June 2, 2005
Accepted August 9, 2005

Review Article

Use and significance of anti-CCP autoantibodies in rheumatoid arthritis

A. J. W. Zendman 1*, W. J. van Venrooij 1, and G. J. M. Pruijn 1

1 Department of Biochemistry, Nijmegen Center for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.

* To whom correspondence should be addressed.
A. J. W. Zendman, E-mail: h.zendman{at}ncmls.ru.nl



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A A Tieleman, A A d. Broeder, A-E van de Logt, and B G M van Engelen
Strong association between myotonic dystrophy type 2 and autoimmune diseases
J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1293 - 1295.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. D. Doodes, Y. Cao, K. M. Hamel, Y. Wang, B. Farkas, Y. Iwakura, and A. Finnegan
Development of Proteoglycan-Induced Arthritis Is Independent of IL-17
J. Immunol., July 1, 2008; 181(1): 329 - 337.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M.-K. Koivula, E. Savolainen, O. Kaipiainen-Seppanen, H. Kautiainen, R. Luosujarvi, M. Hakala, and J. Risteli
Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series
Rheumatology, May 1, 2008; 47(5): 656 - 659.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. Anzilotti, L. Riente, F. Pratesi, D. Chimenti, A. Delle Sedie, S. Bombardieri, and P. Migliorini
IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders
Rheumatology, October 1, 2007; 46(10): 1579 - 1582.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
F. Bobbio-Pallavicini, R. Caporali, C. Alpini, S. Avalle, O. M Epis, C. Klersy, and C. Montecucco
High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor {alpha} inhibitors in rheumatoid arthritis
Ann Rheum Dis, March 1, 2007; 66(3): 302 - 307.
[Abstract] [Full Text] [PDF]

Home page
 DTBHome page
Combination therapy for early rheumatoid arthritis
DTB, November 1, 2006; 44(11): 81 - 85.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.